Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

45 trials with published results (15%)

Research Maturity

187 completed trials (64% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.5%

22 terminated out of 293 trials

Success Rate

89.5%

+2.9% vs benchmark

Late-Stage Pipeline

24%

69 trials in Phase 3/4

Results Transparency

24%

45 of 187 completed with results

Key Signals

45 with results89% success22 terminated

Data Visualizations

Phase Distribution

251Total
Not Applicable (132)
Early P 1 (2)
P 1 (18)
P 2 (30)
P 3 (19)
P 4 (50)

Trial Status

Completed187
Unknown35
Recruiting23
Terminated22
Not Yet Recruiting11
Withdrawn8

Trial Success Rate

89.5%

Benchmark: 86.6%

Based on 187 completed trials

Clinical Trials (293)

Showing 20 of 20 trials
NCT05669703Recruiting

NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder

NCT07852065Not ApplicableActive Not RecruitingPrimary

iTBS Versus Standard 10 Hz rTMS for Treatment-Resistant Depression (TRD)

NCT07807930Not Yet RecruitingPrimary

Individual Narratives of Stimulation (ECT and TMS)

NCT07691749Not ApplicableRecruitingPrimary

Effect of Psychobiotics With Standard Antiddepressants in Treatment of Major Depressive Disorder

NCT05703412Not ApplicableEnrolling By Invitation

Effectiveness of mHealth Post-discharge Intervention for Patients With Severe Mental Illness

NCT07503002Phase 1Not Yet Recruiting

Shortened LSD Intervention for Major Depressive Disorder

NCT07785102Early Phase 1Not Yet RecruitingPrimary

Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101

NCT07673913Not ApplicableRecruiting

Relationship of Peripheral Inflammatory and Neuroprotective Biomarkers With Response to Intermittent Theta Burst Stimulation in Treatment-Resistant Depression

NCT06580145Phase 2RecruitingPrimary

Leucine in Midlife Depression

NCT03973268Phase 1Recruiting

Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression

NCT07813169Not ApplicableRecruitingPrimary

Study on iTBS Regulating the Reward Circuit Function to Improve Anhedonia in Depression

NCT07807735Not ApplicableNot Yet RecruitingPrimary

Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression. (MDD)

NCT07226011Not ApplicableActive Not RecruitingPrimary

Accelerated High-Dose tDCS for Depression

NCT07593222Phase 1Not Yet RecruitingPrimary

Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder

NCT07226232Phase 3RecruitingPrimary

Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression

NCT05097586Not ApplicableRecruitingPrimary

RCT of At-Home tDCS for Depression in Pregnancy

NCT07748091Recruiting

EEG Microstate Parameters and Neuroinflammatory Biomarkers in Patients With Treatment-Resistant Major Depressive Disorder Receiving ECT

NCT07062783Not ApplicableCompletedPrimary

Effect of Aerobic Exercise on Biomarkers in Depression

NCT07745569Phase 2Not Yet Recruiting

Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies

NCT05497414Not ApplicableCompletedPrimary

Neuroimaging Sleep and Mood in Depression

Scroll to load more

Research Network

Activity Timeline